# Cognitive Changes With Gabapentin Treatment

> **NCT04106011** · — · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 3 (actual)

## Conditions studied

- Neuralgia Peripheral
- Pain

## Interventions

- **DRUG:** Gabapentin
- **DIAGNOSTIC_TEST:** BTACT
- **DIAGNOSTIC_TEST:** BPI
- **DIAGNOSTIC_TEST:** HADS
- **DIAGNOSTIC_TEST:** SLP9
- **DIAGNOSTIC_TEST:** NPSI

## Key facts

- **NCT ID:** NCT04106011
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-10
- **Primary completion:** 2021-02-18
- **Final completion:** 2021-02-18
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** PI request - low enrollment
- **Last updated:** 2021-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04106011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04106011, "Cognitive Changes With Gabapentin Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04106011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*